<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03719625</url>
  </required_header>
  <id_info>
    <org_study_id>prophylactic vasopressors</org_study_id>
    <nct_id>NCT03719625</nct_id>
  </id_info>
  <brief_title>Norepinephrine Versus Ephedrin for Prevention of Post Spinal Anesthesia in Cesarean Section</brief_title>
  <official_title>Norepinephrine Versus Ephedrin for Prevention of Post Spinal Anesthesia in Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mongi Slim Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mongi Slim Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Spinal anesthesia is still the gold standard anesthetic method for elective and urgent
      cesarean section, the post spinal hypotension remains the most frequent complication of this
      procedure and is still responsible of considerable maternel and fetal morbidity. It is
      recommanded to prevent this post spinal hypotension with fluid coloading and prophylactic
      vasopressors administration.

      The aim of this study is to compare the efficency and the safety of norepinephrin and
      ephedrin prophylactic administration to reduce the incidence of post spinal hypotension in
      cesarean section.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Spinal anesthesia is still the gold standard anesthetic method for elective and urgent
      cesarean section, the post spinal hypotension remains the most frequent complication of this
      procedure and is still responsible of considerable maternel and fetal morbidity. It is
      recommanded to prevent this post spinal hypotension with fluid coloading and prophylactic
      vasopressors administration. The prophylactic use of norepinephrin and phenylephrin has been
      validated by several studies, but few data are published concerning the comparaison between
      norepinephrin and ephedrine as preventive vasopressors in cesarean section; these molecules
      act on alpha and beta adrenergic receptors and could provide better maternal hemodynamics in
      parturients undergoing cesarean section under spinal anesthesia.

      The aim of this study is to compare the efficency and the safety of norepinephrin and
      ephedrin prophylactic administration to reduce the incidence of post spinal hypotension in
      cesarean section.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2, 2019</start_date>
  <completion_date type="Anticipated">May 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>controlled, prospective, randomised trial comparing 2 interventions</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of post spinal hypotension</measure>
    <time_frame>during the first 20 minutes after spinal anesthesia</time_frame>
    <description>decrease of systolic arterial blood pressure &gt; 20% baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lowest systolic blood pressure</measure>
    <time_frame>uring the first 20 minutes after spinal anesthesia</time_frame>
    <description>Lowest systolic blood pressure recorded after spinal anesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of bradycardia</measure>
    <time_frame>during the first 20 minutes after spinal anesthesia</time_frame>
    <description>heart rate&lt;50 beats/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of nausea and/or vomiting</measure>
    <time_frame>during the first 20 minutes after spinal anesthesia</time_frame>
    <description>incidence of nausea and/or vomiting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apgar score</measure>
    <time_frame>20min after spinal anesthesia</time_frame>
    <description>Apgar score at 1 min, 5 min, 10 min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fetal ph</measure>
    <time_frame>20min after spinal anesthesia</time_frame>
    <description>fetal ph</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fetal blood lactates</measure>
    <time_frame>20min after spinal anesthesia</time_frame>
    <description>fetal blood lactates</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Maternal Hypotension Syndrome</condition>
  <condition>Cesarean</condition>
  <arm_group>
    <arm_group_label>norepinephrin group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients of this group will recieve 0.5 micro gr/kg of norepinephin intravenously, the infusion will start during the intrathecal injection and during 10 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ephedrin group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients of this group will recieve 0,3mg/kg of Ephedrin intravenously, the infusion will start during the intrathecal injection and during 10 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ephedrine</intervention_name>
    <description>Comparaison of Norepinephrin and Ephedrin for prevention of the post spinal anesthesia in cesarean section</description>
    <arm_group_label>Ephedrin group</arm_group_label>
    <other_name>Ephedrin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Norepinephrine</intervention_name>
    <description>Comparaison of Norepinephrin and Ephedrin for prevention of the post spinal anesthesia in cesarean section</description>
    <arm_group_label>norepinephrin group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  full termed parturients scheduled for elective or semi urgent cesarean section under
             spinal anesthesia

          -  AGE&gt;15 years

          -  ASA II status

          -  No history of hypertension, preeclampsia or cardiopathy

          -  BMI&lt;40

        Exclusion Criteria:

          -  cesarean section under genearl anesthesia or epidural analgesia during labor
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>this study is exclusively including paturients undergoing cesarean section</gender_description>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Asma Ben Souissi, assistant professor</last_name>
    <phone>0021698336883</phone>
    <email>bsouissiasma@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mhamed Sami Mebazaa, Professor</last_name>
    <phone>0021622252589</phone>
    <email>msmebazaa@gmail.com</email>
  </overall_contact_backup>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 19, 2018</study_first_submitted>
  <study_first_submitted_qc>October 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2018</study_first_posted>
  <last_update_submitted>November 30, 2018</last_update_submitted>
  <last_update_submitted_qc>November 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mongi Slim Hospital</investigator_affiliation>
    <investigator_full_name>Mhamed Sami Mebazaa</investigator_full_name>
    <investigator_title>Head of the anesthesia intensive care department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Norepinephrine</mesh_term>
    <mesh_term>Ephedrine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

